Endpoints News senior editor Amber Tong is leaving the biopharma news site for a new opportunity.
In addition to writing on the biggest scientific and business updates of the day, she steers coverage decisions for the newsroom and sets the agenda before the U.S. and Europe are awake. She has a particular focus on oncology, and how technologies developed for cancer are being used in other diseases.
Working out of Hong Kong, she has also helped bring attention to the growing role Asia plays on the global biopharma stage.
Tong is a graduate of Rice University, with a degree in anthropology.
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…